Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 1
1995 1
2004 3
2005 3
2006 1
2007 5
2008 7
2009 2
2010 5
2011 2
2012 2
2014 1
2015 2
2016 5
2017 4
2018 3
2019 7
2020 10
2021 13
2022 15
2023 14
2024 16
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire.
Andreu-Sánchez S, Bourgonje AR, Vogl T, Kurilshikov A, Leviatan S, Ruiz-Moreno AJ, Hu S, Sinha T, Vich Vila A, Klompus S, Kalka IN, de Leeuw K, Arends S, Jonkers I, Withoff S; Lifelines Cohort Study; Brouwer E, Weinberger A, Wijmenga C, Segal E, Weersma RK, Fu J, Zhernakova A. Andreu-Sánchez S, et al. Among authors: de leeuw k. Immunity. 2023 Jun 13;56(6):1376-1392.e8. doi: 10.1016/j.immuni.2023.04.003. Epub 2023 May 9. Immunity. 2023. PMID: 37164013 Free article.
Sjögren's syndrome, should we sign?
Kroese FG, Verstappen GM, de Leeuw K, Bootsma H. Kroese FG, et al. Among authors: de leeuw k. Expert Rev Clin Immunol. 2016;12(4):365-7. doi: 10.1586/1744666X.2016.1130624. Epub 2016 Jan 16. Expert Rev Clin Immunol. 2016. PMID: 26654746 No abstract available.
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases.
Koers J, Sciarrillo R, Derksen NIL, Vletter EM, Fillié-Grijpma YE, Raveling-Eelsing E, Graça NAG, Leijser T, Pas HH, Laura van Nijen-Vos L, Braham MVJ, Buisman AM, de Jong J, Schriek AI, Tio-Gillen AP, Teng YKO, Steenhuis M, Swaneveld FH, de Taeye SW, van Gils MJ, Verschuuren JJGM, Rutgers B, Heeringa P, Horváth B, Jacobs BC, de Leeuw K, Franssen CFM, Veyradier A, Coppo P, Gelderman KA, Marieke van Ham S, van Els CACM, van der Woude D, Huizinga R, Huijbers MG, Kuijpers TW, Toes REM, Bos NA, Rispens T; T2B Consortium. Koers J, et al. Among authors: de leeuw k. J Allergy Clin Immunol. 2023 Jun;151(6):1646-1654. doi: 10.1016/j.jaci.2022.10.035. Epub 2023 Jan 27. J Allergy Clin Immunol. 2023. PMID: 36716825
Patient assessment.
Miloro M, DeLeeuw KA, Ruggiero SL. Miloro M, et al. J Oral Maxillofac Surg. 2012 Nov;70(11 Suppl 3):e12-30. doi: 10.1016/j.joms.2012.07.029. J Oral Maxillofac Surg. 2012. PMID: 23127999 Review. No abstract available.
[Antibiotic prophylaxis and immune-compromised patients].
de Leeuw K, Bootsma H, Middel A, Vissink A. de Leeuw K, et al. Ned Tijdschr Tandheelkd. 2019 Oct;126(10):521-525. doi: 10.5177/ntvt.2019.10.19065. Ned Tijdschr Tandheelkd. 2019. PMID: 31613281 Review. Dutch.
Reply.
Lambers WM, Westra J, Bootsma H, de Leeuw K. Lambers WM, et al. Among authors: de leeuw k. Arthritis Care Res (Hoboken). 2020 Dec;72(12):1827-1828. doi: 10.1002/acr.24462. Arthritis Care Res (Hoboken). 2020. PMID: 32976701 No abstract available.
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Stalman EW, Wieske L, Keijser JBD, van Dam KPJ, Kummer LYL, Wilbrink MF, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Parra Sanchez A, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Onno Teng YK, van Paassen P, Busch MH, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Cristianawati O, Brinke AT, Verstegen NJM, Zwinderman KAH, van Ham SM, Rispens T, Welkers MR, Jonges M, Eftimov F, Kuijpers TW; T2B! immunity against SARS-CoV-2 study group. Stalman EW, et al. Among authors: de leeuw k. J Allergy Clin Immunol. 2024 Sep;154(3):754-766.e7. doi: 10.1016/j.jaci.2024.04.031. Epub 2024 May 17. J Allergy Clin Immunol. 2024. PMID: 38763170 Free article.
108 results